Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Integer Holdings Corp

Healthcare US ITGR

88.73USD
-1.37(1.52%)

Last update at 2026-06-23T18:36:00Z

Day Range

86.9790.97
LowHigh

52 Week Range

63.00100.26
LowHigh

Fundamentals

  • Previous Close 90.10
  • Market Cap3288.00M
  • Volume114715
  • P/E Ratio40.77
  • Dividend Yield1.63%
  • EBITDA269.82M
  • Revenue TTM1555.94M
  • Revenue Per Share TTM46.77
  • Gross Profit TTM 359.01M
  • Diluted EPS TTM2.42

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 75.96M 101.06M 86.21M 105.19M 61.12M
Minority interest - - - - -
Net income 66.38M 96.81M 77.26M 96.34M 167.96M
Selling general administrative 160.58M 141.42M 109.01M 138.69M 115.79M
Selling and marketing expenses - - - - -
Gross profit 359.01M 336.97M 285.71M 355.01M 362.67M
Reconciled depreciation 91.99M 81.37M 79.32M 77.89M 88.99M
Ebit 121.33M 135.71M 120.61M 157.63M 154.80M
Ebitda 222.76M 214.06M 203.75M 236.11M 243.79M
Depreciation and amortization 101.44M 78.35M 83.14M 78.47M 88.99M
Non operating income net other 0.90M 0.12M -1.52200M 0.58M -0.75200M
Operating income 121.33M 135.71M 120.61M 157.63M 155.56M
Other operating expenses 1238.59M 1085.37M 952.83M 1100.46M 1059.46M
Interest expense 38.63M 31.63M 38.22M 52.55M 99.31M
Tax provision 10.61M 8.04M 8.95M 13.97M 14.08M
Interest income - - - 55.52M -
Net interest income -38.63200M -31.62800M -38.22000M -52.54500M -99.31000M
Extraordinary items - - - 5.12M 109.93M
Non recurring - - - - -
Other items - - - - -
Income tax expense 10.61M 8.04M 8.95M 13.97M 14.08M
Total revenue 1376.10M 1221.08M 1073.44M 1258.09M 1215.01M
Total operating expenses 221.50M 201.26M 165.09M 197.38M 207.11M
Cost of revenue 1017.09M 884.11M 787.74M 903.08M 852.35M
Total other income expense net -45.36900M -34.64800M -34.40500M -52.44200M 4.87M
Discontinued operations 1.03M 3.79M 3.79M 5.12M 188.31M
Net income from continuing ops 65.35M 93.02M 77.26M 91.22M 47.03M
Net income applicable to common shares 66.38M 96.81M 77.26M 96.34M 167.96M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2794.39M 2582.22M 2371.86M 2353.09M 2326.68M
Intangible assets 819.89M 807.81M 757.22M 775.78M 812.34M
Earning assets - - - - -
Other current assets 27.00M 27.61M 15.90M 17.85M 15.10M
Total liab 1376.93M 1227.52M 1100.80M 1200.61M 1266.19M
Total stockholder equity 1417.46M 1354.70M 1271.06M 1152.49M 1060.49M
Deferred long term liab - 171.50M 182.30M 187.98M 203.91M
Other current liab 78.81M 53.88M 56.19M 67.12M 67.40M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings 680.70M 614.32M 517.52M 440.26M 344.50M
Other liab 172.79M 195.25M 212.99M 204.33M 213.61M
Good will 982.19M 924.70M 859.44M 839.62M 832.34M
Other assets 17.39M 49.57M 88.29M 11.47M 7.50M
Cash 24.27M 17.89M 49.21M 13.54M 25.57M
Cash and equivalents - - - - -
Total current liabilities 223.75M 159.63M 156.19M 179.08M 164.57M
Current deferred revenue 5.62M 3.78M 2.50M 1.98M 2.48M
Net debt 983.41M 879.87M 728.34M 845.86M 899.94M
Short term debt 28.55M 25.11M 45.93M 45.01M 37.50M
Short long term debt 18.19M 15.25M 37.50M 37.50M 37.50M
Short long term debt total 1007.68M 897.75M 777.55M 859.39M 925.51M
Other stockholder equity 731.39M 713.15M 700.81M 692.21M 682.96M
Property plant equipment 317.24M 347.15M 253.96M 246.19M 231.27M
Total current assets 558.30M 452.98M 412.94M 415.39M 416.25M
Long term investments - - - 22.26M 26.99M
Net tangible assets 1417.46M -377.81700M -345.61100M -462.91300M -584.18300M
Short term investments - - - - -
Net receivables 298.25M 251.79M 198.51M 216.75M 185.50M
Long term debt 907.07M 812.88M 693.76M 777.27M 888.01M
Inventory 208.77M 155.70M 149.32M 167.26M 190.08M
Accounts payable 110.78M 76.86M 51.57M 64.97M 57.19M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 5.33M 27.19M 52.69M 19.99M 33.00M
Additional paid in capital - - - - -
Common stock total equity 0.03M 0.03M 0.03M 0.03M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity 680.70M 614.32M 517.52M 440.26M 344.50M
Treasury stock - - - -8.80900M -8.12500M
Accumulated amortization - - - - -
Non currrent assets other 26.86M 43.86M 38.74M 29.30M 30.55M
Deferred long term asset charges - - - - -
Non current assets total 2236.09M 2129.23M 1958.92M 1937.70M 1910.43M
Capital lease obligations 82.42M 69.63M 46.29M 44.62M -
Long term debt total - 812.88M 693.76M 777.27M 888.01M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.30M -270.99800M -56.57600M -58.86200M 536.67M
Change to liabilities 29.03M 19.52M -24.11800M -5.81900M -11.64100M
Total cashflows from investing activities -200.42100M -270.99800M -56.57600M -58.86200M 536.67M
Net borrowings 95.75M 95.59M -88.01500M -117.88500M -732.46000M
Total cash from financing activities 92.48M 81.99M -88.57800M -117.92600M -725.08000M
Change to operating activities -8.76500M -25.39300M -11.58500M -33.80400M -3.22900M
Net income 66.38M 96.81M 77.26M 96.34M 167.96M
Change in cash 6.39M -31.32100M 35.67M -12.03400M -18.52700M
Begin period cash flow 17.89M 49.21M 13.54M 25.57M 44.10M
End period cash flow 24.27M 17.89M 49.21M 13.54M 25.57M
Total cash from operating activities 116.38M 156.67M 181.34M 165.36M 167.30M
Issuance of capital stock - - - - -
Depreciation 91.99M 81.37M 79.32M 77.89M 88.99M
Other cashflows from investing activities -125.99700M -217.53500M -9.74400M -10.66400M 581.58M
Dividends paid - - - - -
Change to inventory -56.72100M 4.70M 18.44M 3.72M -16.09400M
Change to account receivables -41.38000M -17.53900M 38.15M -6.97600M 9.29M
Sale purchase of stock 0.15M 0.74M 3.26M 3.24M 12.41M
Other cashflows from financing activities 163.42M 886.94M 183.93M 32.57M -19.61100M
Change to netincome 13.27M 19.28M 0.80M -6.12700M -123.22100M
Capital expenditures 74.73M 53.46M 51.44M 48.20M 44.91M
Change receivables -41.38000M -17.53900M 38.15M -6.97600M 9.29M
Cash flows other operating 11.77M -16.30200M -13.28800M -1.44700M 2.90M
Exchange rate changes - - - - 2.58M
Cash and cash equivalents changes 8.44M -32.34600M 36.19M -11.43000M -18.52700M
Change in working capital -75.84700M -47.74500M 16.16M -40.13100M -9.91900M
Stock based compensation 21.02M 16.18M 9.16M 9.29M 10.47M
Other non cash items 30.34M 20.32M 6.40M 32.25M -151.33000M
Free cash flow 41.65M 103.20M 129.90M 117.16M 122.39M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ITGR
Integer Holdings Corp		 -1.37 1.52% 88.73 40.77 18.80 2.13 2.22 2.72 16.94
ABT
Abbott Laboratories		 2.70 3.07% 90.53 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 3.72 1.22% 308.41 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 1.36 1.72% 80.63 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 1.27 2.86% 45.60 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Integer Holdings Corp

5830 Granite Parkway, Plano, TX, United States, 75024

Key Executives

Name Title Year Born
Mr. Joseph W. Dziedzic Pres, CEO & Director 1968
Mr. Jason K. Garland Exec. VP & CFO 1974
Ms. Jennifer M. Bolt Exec. VP of Global Operations & ESG 1969
Mr. Payman Khales Pres of Cardio & Vascular 1970
Mr. Anthony W. Borowicz Sr. VP of Investor Relations 1957
Mr. McAlister C. Marshall II Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. 1970
Mr. Kirk K. Thor Exec. VP & Chief HR Officer 1964
Mr. Carter Houghton Pres of Electrochem & Power Solutions 1969
Ms. Margaret Carthy Sr. VP of Quality & Regulatory Affairs 1964
Mr. Andrew Senn Sr. VP of Strategy and Bus. Devel. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.